Compare MATK to:
After Hours: 17.6965 N/A (N/A) 1:17pm ET
| Last Trade: | 17.70 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 18.09 |
| Open: | 17.67 |
| Bid: | N/A |
| Ask: | 20.75 x 100 |
| 1y Target Est: | 28.25 |
| Day's Range: | 17.36 - 18.05 |
|---|---|
| 52wk Range: | 15.36 - 31.60 |
| Volume: | 171,408 |
| Avg Vol (3m): | 318,705 |
| Market Cap: | 588.33M |
| P/E (ttm): | 14.76 |
| EPS (ttm): | 1.20 |
| Div & Yield: | N/A (N/A) |
| Thu, Nov 19 | Lightning Round OT: Martek Biosciences, Valmont Industries and Moreat CNBC |
| Tue, Oct 20 | Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan AnalystWall Street Transcript |
| Mon, Sep 21 | Martek's life'sDHA(TM) Featured in New Nutrioli DHA Cooking Oil from RagasaPR Newswire |
| Fri, Sep 18 | MARTEK BIOSCIENCES CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online |
| Thu, Sep 17 | MARTEK BIOSCIENCES CORP FinancialsEDGAR Online Financials |
| Wed, Sep 16 | Martek Announces Addition to Its Board of DirectorsPR Newswire |
| Tue, Sep 15 | Martek to Present at Two Upcoming Investor ConferencesPR Newswire |
| Thu, Sep 10 | Martek Announces Settlement of Patent Dispute with Capsugel FrancePR Newswire |
| Wed, Sep 9 | MARTEK BIOSCIENCES CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Tue, Sep 8 | Federal Circuit Rules in Martek's Favor in Appeal of Patent Infringement CasePR Newswire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.